Medical Writers News Hubb
Advertisement Banner
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home News

7 cardiology startups you need to know

admin by admin
April 26, 2023
in News


Clockwise from top left: Safebeat Rx’s AFib remote monitoring, LiveMetric wearable blood pressure monitor, Respirix’s Cardiospire noninvasive hemodynamic monitor, CardiaCare wearable noninvasive nerve stimulator {images courtesy of the companies]

In the fast-evolving field of cardiology, medical device startups are emerging as key players, bringing new ideas and technologies to the table.

With a focus on agility and creativity, cardiology medical device startups are challenging established players in the industry and disrupting traditional models of healthcare delivery. From wearables and remote monitoring devices to AI-powered diagnostics and minimally invasive procedures, these startups are redefining what is possible in the world of cardiology.

Investors are taking notice of the potential of these startups, pouring millions of dollars into their ventures. As a result, many of these companies are experiencing rapid growth and expanding their reach across the globe.

As the cardiology landscape continues to evolve, medical device startups are likely to play an increasingly important role in shaping the future of the industry. These seven companies are developing innovative solutions that aim to improve the diagnosis, treatment and management of cardiovascular diseases.

The seven startups below (and 15 others) will showcase their technology as a part of MedTech Innovator’s accelerator program pitches at DeviceTalks Boston on May 10-11.

CardiaCare: Closed-loop wearable for noninvasive treatment of cardiac clinical symptoms

Rehovot, Israel
Founded:
2015

CardiaCare is a clinical-stage digital therapeutic company that is developing a closed-loop wearable device for the noninvasive treatment of cardiac and other central nervous system-related clinical symptoms. The nerve stimulation system has continuous monitoring and AI-based alert capabilities to enable complete remote patient management and personalized treatment.

The company currently has a functional prototype and has successfully completed a first-in-man study. CardiaCare is also a 2022 MedTech Innovator cohort company.

Check out CardiaCare’s technology during the MedTech Innovator pitch session at DeviceTalks Boston, May 10-11. Register for the conference here.

LiveMetric: Continuous blood pressure wearable

Luxembourg
Founded:
2016

LiveMetric is the only FDA-cleared, calibration-free, cuff-free, continuous blood pressure wearable that provides thousands of measurements per month. The measurements are digitally transmitted to a provider to help make important care and treatment decisions. The company’s LiveOne device uses algorithms that analyze a person’s radial artery pressure to produce diastolic, systolic and pulse rates for people ages 27 and up.

Check out LiveMetric’s technology during the MedTech Innovator pitch session at DeviceTalks Boston, May 10-11. Register for the conference here.

Respirix: Cardiospire noninvasive hemodynamic monitoring

San Francisco
Founded:
2015

Respirix’s Cardiospire technology is a new approach to noninvasive hemodynamic monitoring using airway pressure for continuous, high-fidelity modeling of stroke volume and pulmonary artery pressures. Cardiospire is placed inline using a capnography adapter and provides accurate AI modeling of core hemodynamic parameters. It displaces the catheterization risk and removes the guesswork from hemodynamic management to improve patient outcomes.

Check out Respirix’s technology during the MedTech Innovator pitch session at DeviceTalks Boston, May 10-11. Register for the conference here.

Safebeat Rx: Cardiac implantable electronic device monitoring

St. Louis, Missouri
Founded:
2020

SafeBeat has developed technology that expands access to remote patient monitoring, continuous telemetry and event monitoring. It also has software-enabled remote therapeutic monitoring and cardiac implantable electronic device monitoring powered by automated artificial intelligence-based software. According to the company, the system has ECG interpretation and treatment management coupled with AI to increase physician efficiency with automated insights.



Source link

Previous Post

all you need to know about ELISAs

Next Post

COVID-19 diagnosis among pregnant and postpartum individuals showed distinct patterns by rurality of residence and select pregnancy conditions

Next Post

COVID-19 diagnosis among pregnant and postpartum individuals showed distinct patterns by rurality of residence and select pregnancy conditions

Recommended

New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness

1 month ago

What is currently known about the mechanisms by which DNA tumor viruses evade uracil-mediated antiviral immunity?

2 months ago

Researchers secure $20.5 million NIH grant to beat Alzheimer’s disease and related dementias

9 months ago

Direct oral anticoagulants more effective and cost-effective for treating cancer-associated thrombosis

5 months ago

BioEcho Achieves My Green Lab® Certification

3 months ago

SARS-CoV-2 envelope structural protein found to form voltage-activated and calcium-activated calcium channels

8 months ago
Medical-Writers-(-white-)

© Medical Writers News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Papers
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Papers
  • Contact

© 2022 Medical Writers News Hubb All rights reserved.